Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7006)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2016 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Domagalski K, Pawłowska M, Zaleśna A, Pilarczyk M, Rajewski P, Halota W, Tretyn A. Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus. World J Gastroenterol 2016; 22(41): 9186-9195 [PMID: 27895405 DOI: 10.3748/wjg.v22.i41.9186] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i41/9186.htm |
| Number | Citing Articles |
| 1 |
Laith N. AL‐Eitan, Saif Z. Alahmad. Pharmacogenomics of genetic polymorphism within the genes responsible for SARS‐CoV‐2 susceptibility and the drug‐metabolising genes used in treatment. Reviews in Medical Virology 2021; 31(4) doi: 10.1002/rmv.2194
|
| 2 |
Sang-Yu Ying, Yao-Ren Hu, Guo-Sheng Gao, Ke-Hong Lou, Zhen Huang. Interleukin-28B Polymorphisms Predict the Efficacy of Peginterferon Alpha in Patients With Chronic Hepatitis B: A Meta-Analysis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.691365
|
| 3 |
Ming-Wei Lai, Mei-Hwei Chang. Updates in the management of hepatitis B in children. Expert Review of Gastroenterology & Hepatology 2019; 13(11): 1065 doi: 10.1080/17474124.2019.1686975
|
| 4 |
Sanja Kiprijanovska, Emilija Sukarova Stefanovska, Predrag Noveski, Viktorija Chaloska Ivanova, Dijana Plaseska-Karanfilska. Influence of OASL gene polymorphisms on host response to interferon therapy in chronic hepatitis C virus patients. The EuroBiotech Journal 2017; 1(2): 117 doi: 10.24190/ISSN2564-615X/2017/02.02
|
| 5 |
Anmol Gokul, Thilona Arumugam, Veron Ramsuran. Genetic Ethnic Differences in Human 2′-5′-Oligoadenylate Synthetase and Disease Associations: A Systematic Review. Genes 2023; 14(2): 527 doi: 10.3390/genes14020527
|
| 6 |
Qiqi Zeng, Yi Ren, Yanyan Wang, Jiaxin Yang, Yi Qin, Lijuan Yang, Xinrui Zheng, Ailong Huang, Hui Fan. The nuclear matrix protein HNRNPU restricts hepatitis B virus transcription by promoting OAS3‐based activation of host innate immunity. Journal of Medical Virology 2024; 96(7) doi: 10.1002/jmv.29805
|
| 7 |
Enrico Galmozzi, Floriana Facchetti, Glenda Grossi, Alessandro Loglio, Mauro Viganò, Giovanna Lunghi, Massimo Colombo, Pietro Lampertico. IFNL4 rs368234815 and rs117648444 variants predict off‐treatment HBsAg seroclearance in IFN‐treated HBeAg‐negative chronic hepatitis B patients. Liver International 2018; 38(3): 417 doi: 10.1111/liv.13526
|
| 8 |
S. Wang, J. Wang, M‐J. Fan, T‐Y. Li, H. Pan, X. Wang, H‐K. Liu, Q‐F. Lin, J‐G. Zhang, L‐P. Guan, D. V. Zhernakova, S. J. O’Brien, Z‐R. Feng, L. Chang, E‐H. Dai, J‐H. Lu, H‐L. Xi, Z. Zeng, Y‐Y. Yu, B‐B. Wang. Identified OAS3 gene variants associated with coexistence of HBsAg and anti‐HBs in chronic HBV infection. Journal of Viral Hepatitis 2018; 25(8): 904 doi: 10.1111/jvh.12899
|
| 9 |
Qirong Li, Baozhen Sun, Yue Zhuo, Ziping Jiang, Rong Li, Chao Lin, Ye Jin, Yongjian Gao, Dongxu Wang. Interferon and interferon-stimulated genes in HBV treatment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1034968
|
| 10 |
Yongli Guo, Zhifeng Song, Xintong Cheng, Yujiao Wang, Xiuxin Luo, Ran An, Junwei Wang, Mingchun Gao. Molecular and functional characterization of ovis aries IFN-epsilon. Molecular Immunology 2020; 119: 1 doi: 10.1016/j.molimm.2020.01.001
|
| 11 |
Ambika Sharma, Ajay Duseja, Jyoti Parkash, Harish Changotra. Association of IRGM gene promoter polymorphisms with hepatitis B virus infection. The Journal of Gene Medicine 2022; 24(7) doi: 10.1002/jgm.3433
|
| 12 |
Zhongyi Zhao, Zhen Qin, Linlin Zhou, Li Xiang, Jiangzhou You, Ranran Cao, Hongren Wang, Baoning Wang, Mingyuan Li. The impact of IFNL3 genotype on interferon treatment outcome in patients chronically infected with hepatitis B virus: A meta-analysis. Microbial Pathogenesis 2019; 134: 103598 doi: 10.1016/j.micpath.2019.103598
|
| 13 |
Feng Zang, Ming Yue, Yinan Yao, Mei Liu, Haozhi Fan, Yue Feng, Xueshan Xia, Peng Huang, Rongbin Yu. Influence ofIL28BandMxAgene polymorphisms on HCV clearance in Han Chinese population. Epidemiology and Infection 2018; 146(3): 379 doi: 10.1017/S0950268817002928
|